True spectrum of 14q32 translocations in multiple myeloma

被引:0
作者
Pratt, G [1 ]
Fenton, JAL [1 ]
Proffitt, JA [1 ]
Rawstron, AC [1 ]
Davies, FE [1 ]
Child, JA [1 ]
Morgan, GJ [1 ]
机构
[1] Univ Leeds, Gen Infirm, Dept Haematol, United Leeds Teaching Hosp, Leeds LS1 3EX, W Yorkshire, England
关键词
multiple myeloma; t(11; 14); cyclin D1 expression;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1209 / 1210
页数:2
相关论文
共 50 条
[41]   Soft Tissue Plasmacytoma of the Orbit as Part of the Spectrum of Multiple Myeloma [J].
Lazaridou, Marie-Noelle ;
Micallef-Eynaud, Paul ;
Hanna, Ivan T. .
ORBIT-THE INTERNATIONAL JOURNAL ON ORBITAL DISORDERS-OCULOPLASTIC AND LACRIMAL SURGERY, 2007, 26 (04) :315-318
[42]   Prognostic value of 1q21 amplification in multiple myeloma [J].
Abramova, T. V. ;
Obukhova, T. N. ;
Mendeleev, L. P. ;
Pokrovskaya, O. S. ;
Gribanova, E. O. ;
Ryzhko, V. V. ;
Grebenyuk, L. A. ;
Nareyko, M. V. ;
Solovyev, M. V. ;
Votyakova, O. M. ;
Kulikov, S. M. ;
Rusinov, M. A. ;
Savchenko, V. G. .
TERAPEVTICHESKII ARKHIV, 2017, 89 (07) :32-+
[43]   Founding precision therapy for 1q-amplified multiple myeloma [J].
Sklavenitis-Pistofidis, Romanos ;
Reidy, Mairead ;
Huynh, Daisy ;
Zavidij, Oksana ;
Berrios, Brianna ;
Park, Jihye ;
Shen, Yujia ;
Salem, Karma ;
Glavey, Siobhan ;
Leleu, Xavier ;
Root, David ;
Ghobrial, Irene ;
Manier, Salomon .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10) :E50-E50
[44]   AL amyloidosis and progression to multiple myeloma with gain(1q) [J].
Hoffman, James ;
Jhanwar, Suresh ;
Comenzo, Raymond L. .
BRITISH JOURNAL OF HAEMATOLOGY, 2009, 144 (06) :963-964
[45]   Prognostic Value of 1q21 Gain in Multiple Myeloma [J].
Chen, Dangui ;
Zhou, Di ;
Xu, Jingyan ;
Zhou, Rongfu ;
Ouyang, Jian ;
Chen, Bing .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (03) :E159-E164
[46]   Multiple myeloma with t(11;14): unique biology and evolving landscape [J].
Bal, Susan ;
Kumar, Shaji K. ;
Fonseca, Rafael ;
Gay, Francesca ;
Hungria, Vania Tm ;
Dogan, Ahmet ;
Costa, Luciano J. .
AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (07) :2950-2965
[47]   Impact of t(11;14) in Multiple Myeloma on Response to Treatment and Survival [J].
Puertas, Borja ;
Sobejano, Eduardo ;
Gomez, Sandra ;
Hernandez, Alberto ;
Alejo, Elena ;
Alonso, David ;
Maria Navarro, Jose ;
Puerta, Carlos ;
Garcia, Pablo ;
Zapata, Evelyn ;
Redondo, Elena ;
Rey, Beatriz ;
Gutierrez, Norma ;
Puig, Noemi ;
Garcia-Sanz, Ramon ;
Victoria Mateos, Maria ;
Escalante, Fernando ;
Gonzalez-Calle, Veronica .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 :S413-S414
[48]   Effects of a novel proteasome inhibitor BU-32 on multiple myeloma cells [J].
Sudipa S. Roy ;
Nameer B. Kirma ;
Bindu Santhamma ;
Rajeshwar R. Tekmal ;
Joseph K. Agyin .
Cancer Chemotherapy and Pharmacology, 2014, 73 :1263-1271
[49]   Effects of a novel proteasome inhibitor BU-32 on multiple myeloma cells [J].
Roy, Sudipa S. ;
Kirma, Nameer B. ;
Santhamma, Bindu ;
Tekmal, Rajeshwar R. ;
Agyin, Joseph K. .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (06) :1263-1271
[50]   Extramedullary plasmacytoma with a t(11;14)(q13;q32) and aggressive clinical course [J].
Parkins, Elizabeth ;
Boll, Maayke ;
O'Connor, Sheila J. M. ;
Rawstron, Andy C. ;
Owen, Roger G. .
LEUKEMIA & LYMPHOMA, 2010, 51 (07) :1360-1362